Emergence of streptococcus pneumoniae serogroups 15 and 35 in nasopharyngeal cultures from young children with acute otitis media

Pediatric Infectious Disease Journal

Volumn 33, Issue 11, 2014, Pages e286-e290

  Martin, Judith M ^a   Hoberman, Alejandro ^a   Paradise, Jack L ^a   Barbadora, Karen A ^a   Shaikh, Nader ^a   Bhatnagar, Sonika ^a   Shope, Timothy ^a   Block, Stan L ^b   Haralam, Mary Ann ^a   Kurs Lasky, Marcia ^a   Colborn, D Kathleen ^a   Green, Michael ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b Kentucky Pediatric Research Institute   (United States)

Author keywords

Acute otitis media; Nasopharyngeal colonization; Serotypes; Streptococcus pneumoniae; Vaccine

Indexed keywords

AMOXICILLIN; CLAVULANIC ACID; OXACILLIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; 13-VALENT PNEUMOCOCCAL VACCINE;

ACUTE OTITIS MEDIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNGEAL ASPIRATION; NASOPHARYNX; PRIORITY JOURNAL; SEROTYPE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; ACUTE DISEASE; CLASSIFICATION; DISK DIFFUSION; HETEROZYGOTE; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; OTITIS MEDIA; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTION;

ACUTE DISEASE; CARRIER STATE; DISK DIFFUSION ANTIMICROBIAL TESTS; FEMALE; HUMANS; INFANT; MALE; NASOPHARYNX; OTITIS MEDIA; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROGROUP; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84926101514     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000445     Document Type: Article

References (24)

1. Kaplan SL, Mason EO Jr, Barson WJ, et al. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics. 1998;102(3 Pt 1):538-545.
2. Whitney CG, Pilishvili T, Farley MM, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet. 2006;368:1495-1502.
3. Pilishvili T, Lexau C, Farley MM, et al.; Active Bacterial Core Surveillance/Emerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201:32-41.
4. Eskola J, Kilpi T, Palmu A, et al.; Finnish Otitis Media Study Group. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403-409.
5. Ray GT, Pelton SI, Klugman K P, et al. Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United States. Vaccine. 2009;27:6483-6494.
6. Millar E V, Watt J P, Bronsdon MA, et al. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members. Clin Infect Dis. 2008;47:989-996.
7. Hoberman A, Paradise JL, Shaikh N, et al. Pneumococcal resistance and serotype 19A in Pittsburgh-area children with acute otitis media before and after introduction of 7-valent pneumococcal polysaccharide vaccine. Clin Pediatr (Phila). 2011;50:114-120.
8. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007;298:1772-1778.
9. Kaplan SL, Barson WJ, Lin PL, et al. Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. Pediatrics. 2010;125:429-436.
10. Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004;23:829-833.
11. Casey JR, Kaur R, Friedel VC, et al. Acute otitis media otopathogens during 2008 to 2010 in Rochester, New York. Pediatr Infect Dis J. 2013;32:805-809.
12. Centers for Disease C, Prevention. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010. MMWR. 2010;59:258-261.
13. Cohen R, Levy C, Bingen E, et al. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media. Pediatr Infect Dis J. 2012;31:297-301.
14. Kaplan SL, Barson WJ, Lin PL, et al. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013;32:203-207.
15. Azzari C, Martinon-Torres F, Schmitt HJ, et al. Evolving role of 13-valent pneumococcal conjugate vaccine in clinical practice. Pediatr Infect Dis J. 2014;33:858-864.
16. Hoberman A, Greenberg D P, Paradise JL, et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA. 2003;290:1608-1616.
17. Hoberman A, Paradise JL, Rockette HE, et al. Treatment of acute otitis media in children under 2 years of age. N Engl J Med. 2011;364:105-115.
18. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. Wayne, PA: Clinical Laboratory Standards Institute; 2009.
19. Wroe PC, Lee GM, Finkelstein JA, et al. Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine. Pediatr Infect Dis J. 2012;31:249-254.
20. Huang SS, Hinrichsen VL, Stevenson AE, et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics. 2009;124:e1-11.
21. Finkelstein JA, Huang SS, Daniel J, et al. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics. 2003;112:862-869.
22. Pelton SI, Loughlin AM, Marchant CD. Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates. Pediatr Infect Dis J. 2004;23:1015-1022.
23. Moore MR, Hyde TB, Hennessy TW, et al. Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. J Infect Dis. 2004;190:2031-2038.
24. Eldan M, Leibovitz E, Piglansky L, et al. Predictive value of pneumococcal nasopharyngeal cultures for the assessment of nonresponsive acute otitis media in children. Pediatr Infect Dis J. 2000;19:298-303.